Last updated: November 15, 2021
Sponsor: Boston Children's Hospital
Overall Status: Completed
Phase
N/A
Condition
Pentalogy Of Cantrell
Treatment
N/AClinical Study ID
NCT02766998
IRB-P00021450
Ages < 1 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All fetal diagnoses of complex congenital heart disease diagnosed by fetalechocardiogram requiring cardiac repair with Blalock-Taussig Shunt or Right Ventricleto Pulmonary Artery conduit will be eligible.
- This includes all pre-natal diagnoses of any single ventricle circulation physiology (SVP).
- Subjects being delivered via cesarean section or vaginally at Brigham and Women'sHospital will be considered.
Exclusion
Exclusion Criteria:
- meconium at delivery
- symptomatic Group B Streptococcus (GBS) positive mothers
- mothers with chorioamnionitis
- Hepatitis B or C positive mothers
- HIV positive mothers.
- If unable to collect viable cord on the day of delivery of already enrolled subjects,the subject will be removed from the study on day of birth.
Study Design
Total Participants: 2
Study Start date:
May 16, 2016
Estimated Completion Date:
November 15, 2021
Connect with a study center
Boston Children's Hospital
Boston, Massachusetts 02115
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.